Twist Bioscience (0ME) Stock Forecast & Price Target

3 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0ME Analyst Ratings

Moderate Buy

8 Buy

2 Hold

1 Sell

Based on 11 analysts giving stock ratings to

Twist

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0ME Stock 12 Month Forecast

Average Price Target

€141.55

▲(9.35% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is €141.55 with a high forecast of €192.49 and a low forecast of €40.29. The average price target represents a 9.35% change from the last price of €129.45.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"€20","193":"€193","63.25":"€63.3","106.5":"€106.5","149.75":"€149.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":192.4898526,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€192.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":141.54718928399998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€141.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40.2885738,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€40.29</span>\n  </div></div>","useHTML":true}}],"tickPositions":[20,63.25,106.5,149.75,193],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.55,171.31460404615385,173.0792080923077,174.84381213846154,176.6084161846154,178.37302023076924,180.13762427692308,181.90222832307694,183.66683236923078,185.4314364153846,187.19604046153847,188.9606445076923,190.72524855384617,{"y":192.4898526,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.55,167.3959376372308,165.24187527446153,163.0878129116923,160.9337505489231,158.77968818615383,156.6256258233846,154.47156346061539,152.31750109784616,150.1634387350769,148.00937637230768,145.85531400953846,143.7012516467692,{"y":141.54718928399998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.55,159.6068133692308,149.66362673846155,139.72044010769233,129.77725347692308,119.83406684615386,109.89088021538463,99.9476935846154,90.00450695384616,80.06132032307693,70.1181336923077,60.17494706153846,50.23176043076924,{"y":40.2885738,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":23.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.98,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.54,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.04,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.68,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.48,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":57.18,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.48,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":114.15,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.55,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€192.49

Average Price Target€141.55

Lowest Price Target€40.29

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Brendan Smith

TD Cowen

€102.96→€170.11

Buy

31.41%

Upside

Reiterated

10/13/26

Twist Bioscience price target raised to $190 from $115 at TD CowenTwist Bioscience price target raised to $190 from $115 at TD Cowen

Kyle Mikson CFA

Canaccord Genuity

€107.44→€183.54

Buy

41.78%

Upside

Reiterated

10/12/26

Twist Bioscience price target raised to $205 from $120 at CanaccordTwist Bioscience price target raised to $205 from $120 at Canaccord

Luke Sergott

Barclays

€100.27→€192.49

Buy

48.70%

Upside

Reiterated

10/07/26

Barclays Remains a Buy on Twist Bioscience (TWST)

Matthew Stanton, CFA

Jefferies

€134.3

Hold

3.74%

Upside

Initiated

10/07/26

Twist Bioscience initiated with a Hold at JefferiesTwist Bioscience initiated with a Hold at Jefferies

Subbu Nambi

Guggenheim

€95.8→€189.8

Buy

46.62%

Upside

Reiterated

10/01/26

Twist Bioscience price target raised to $212 from $107 at GuggenheimTwist Bioscience price target raised to $212 from $107 at Guggenheim

Puneet Souda

Leerink Partners

€143.25→€170.11

Buy

31.41%

Upside

Reiterated

09/29/26

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

Hamed Khorsand

BWS Financial

€40.29

Sell

-68.88%

Downside

Reiterated

09/18/26

Twist Bioscience Rated Sell as Analyst Cites Limited Strategic Upside from Lilly TuneLab Deal; $45 Price Target Reaffirmed

Unknown Analyst

UBS

Not Ranked

UBS

€128.92

Hold

-0.41%

Downside

Initiated

09/08/26

Twist Bioscience initiated with a Neutral at UBSTwist Bioscience initiated with a Neutral at UBS

David Westenberg

Piper Sandler

€102.96

Buy

-20.46%

Downside

Assigned

08/05/26

Twist Bioscience price target raised to $115 from $85 at Piper SandlerTwist Bioscience price target raised to $115 from $85 at Piper Sandler

Catherine Ramsey Schulte

Robert W. Baird

€101.17→€102.96

Buy

-20.46%

Downside

Reiterated

08/04/26

Twist Bioscience price target raised to $115 from $113 at BairdTwist Bioscience price target raised to $115 from $113 at Baird

Matt Larew

William Blair

―

Buy

―

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)

Vijay Kumar

Evercore ISI

€59.09→€91.32

Hold

-29.45%

Downside

Downgraded

07/06/26

Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI

Steven Etoch

Stephens

€36.71

Buy

-71.64%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Brendan Smith

TD Cowen

€102.96→€170.11

Buy

31.41%

Upside

Reiterated

10/13/26

Twist Bioscience price target raised to $190 from $115 at TD CowenTwist Bioscience price target raised to $190 from $115 at TD Cowen

Kyle Mikson CFA

Canaccord Genuity

€107.44→€183.54

Buy

41.78%

Upside

Reiterated

10/12/26

Twist Bioscience price target raised to $205 from $120 at CanaccordTwist Bioscience price target raised to $205 from $120 at Canaccord

Luke Sergott

Barclays

€100.27→€192.49

Buy

48.70%

Upside

Reiterated

10/07/26

Barclays Remains a Buy on Twist Bioscience (TWST)

Matthew Stanton, CFA

Jefferies

€134.3

Hold

3.74%

Upside

Initiated

10/07/26

Twist Bioscience initiated with a Hold at JefferiesTwist Bioscience initiated with a Hold at Jefferies

Subbu Nambi

Guggenheim

€95.8→€189.8

Buy

46.62%

Upside

Reiterated

10/01/26

Twist Bioscience price target raised to $212 from $107 at GuggenheimTwist Bioscience price target raised to $212 from $107 at Guggenheim

Puneet Souda

Leerink Partners

€143.25→€170.11

Buy

31.41%

Upside

Reiterated

09/29/26

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

Hamed Khorsand

BWS Financial

€40.29

Sell

-68.88%

Downside

Reiterated

09/18/26

Twist Bioscience Rated Sell as Analyst Cites Limited Strategic Upside from Lilly TuneLab Deal; $45 Price Target Reaffirmed

Unknown Analyst

UBS

Not Ranked

UBS

€128.92

Hold

-0.41%

Downside

Initiated

09/08/26

Twist Bioscience initiated with a Neutral at UBSTwist Bioscience initiated with a Neutral at UBS

David Westenberg

Piper Sandler

€102.96

Buy

-20.46%

Downside

Assigned

08/05/26

Twist Bioscience price target raised to $115 from $85 at Piper SandlerTwist Bioscience price target raised to $115 from $85 at Piper Sandler

Catherine Ramsey Schulte

Robert W. Baird

€101.17→€102.96

Buy

-20.46%

Downside

Reiterated

08/04/26

Twist Bioscience price target raised to $115 from $113 at BairdTwist Bioscience price target raised to $115 from $113 at Baird

Matt Larew

William Blair

―

Buy

―

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and Twist Bioscience (NASDAQ: TWST)

Vijay Kumar

Evercore ISI

€59.09→€91.32

Hold

-29.45%

Downside

Downgraded

07/06/26

Twist Bioscience downgraded to In Line from Outperform at Evercore ISITwist Bioscience downgraded to In Line from Outperform at Evercore ISI

Steven Etoch

Stephens

€36.71

Buy

-71.64%

Downside

Initiated

11/03/25

Twist Bioscience initiated with an Overweight at StephensTwist Bioscience initiated with an Overweight at Stephens

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

MDWDMediwound

OVIDOvid Therapeutics

IMUXImmunic

ASNDAscendis Pharma

AORTArtivion

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Twist Bioscience

3 Months

Brendan SmithTD Cowen

Success Rate

10/15 ratings generated profit

Average Return

+23.55%

Copying Brendan Smith's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +23.55% per trade.

1 Year

Brendan SmithTD Cowen

Success Rate

11/15 ratings generated profit

Average Return

+164.41%

Copying Brendan Smith's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +164.41% per trade.

2 Years

Brendan SmithTD Cowen

Success Rate

15/15 ratings generated profit

Average Return

+296.01%

Copying Brendan Smith's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +296.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0ME Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0ME has received 12 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. 0ME average Analyst price target in the past 3 months is 141.55.

Each month's total comprises the sum of three months' worth of ratings.

0ME Financial Forecast

0ME Earnings Forecast

Next quarter’s earnings estimate for 0ME is -€0.34 with a range of -€0.40 to -€0.30. The previous quarter’s EPS was -€0.50. 0ME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Sales Forecast

Next quarter’s sales forecast for 0ME is €110.65M with a range of €110.20M to €111.28M. The previous quarter’s sales results were €105.98M. 0ME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0ME has Performed in-line its overall industry.

0ME Stock Forecast FAQ

What is DE:0ME’s average 12-month price target, according to analysts?

Based on analyst ratings, Twist Bioscience Corp’s 12-month average price target is 141.55.

What is DE:0ME’s upside potential, based on the analysts’ average price target?

Twist Bioscience Corp has 9.35% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Twist Bioscience Corp a Buy, Sell or Hold?

Twist Bioscience Corp has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 2 hold ratings and 1 sell ratings.

What is Twist Bioscience Corp’s share price target?

The average share price target for Twist Bioscience Corp is 141.55. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €192.49 ,and the lowest forecast is €40.29. The average share price target represents 9.35% Increase from the current price of €129.45.

What do analysts say about Twist Bioscience Corp?

Twist Bioscience Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Twist Bioscience Corp?

To buy shares of DE:0ME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Twist Bioscience (0ME) Stock Forecast & Price Target

0ME Analyst Ratings

0ME Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Twist Bioscience

0ME Analyst Recommendation Trends

0ME Financial Forecast

0ME Earnings Forecast

0ME Sales Forecast

0ME Stock Forecast FAQ

Detailed List of Analyst Forecasts